Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB26FATVU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,046
Award facts
- Contract value 100% obligated
- $14,045.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,045.73 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 20, 2025. Performance will be executed at the vendor's location in Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as a critical pharmaceutical supplier for Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system, with the company supplying an extensive portfolio including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DB26FATVU?
SPE2DB26FATVU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FATVU worth?
The government has obligated $14,046 on SPE2DB26FATVU.
Is contract SPE2DB26FATVU an order under another contract?
Yes. SPE2DB26FATVU is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATVU competed?
The extent of competition for SPE2DB26FATVU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award